Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$18.0M
+41.1% from 2023
Prescriptions
5,085
$3,541.71 per claim
Patients
1,127
1,106 prescribers
Total spending, 2024
$18.0M
$15,973.55 per patient
Medicare prescription drug plans paid $18.0M for Zerbaxa in 2024, for 5,085 prescriptions and refills to 1,127 patients (up 41.1% from 2023). The average cost per claim was $3,541.71.
Florida had the highest Medicare cost for Zerbaxa in 2024: $2.4M for 722 claims, followed by Texas ($2.0M).
Kavya B Patel, infectious disease in Cincinnati, OH, had the highest Medicare cost for Zerbaxa in 2024: 51 claims costing $360K.
Zerbaxa is made by Merck & Co., Inc. (MRK), listed in the Medicare spending data as Merck Sharp & D.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Kavya B Patel Cincinnati, OH | Infectious Disease | 51 | Under 11 | $360K |
| Kathryn A Ripley Norfolk, VA | Nurse Practitioner | 74 | Under 11 | $325K |
| Karla B Rivera Rivera |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 686 | 3,008 | 670 | $7.2M |
| 2023 | 951 | 4,185 | 966 | $12.8M |
| 2024 | 1,106 | 5,085 | 1,127 | $18.0M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Infectious Disease |
| 41 |
| Under 11 |
| $268K |
| Elizabeth R Ramos-Salazar Houston, TX | Infectious Disease | 43 | Under 11 | $236K |
| Catherine Devoe San Francisco, CA | Infectious Disease | 39 | Under 11 | $233K |
| Daniel Zimmerman Lincolnshire, IL | Infectious Disease | 71 | Under 11 | $232K |
| Paul A Bryant Nashville, TN | Infectious Disease | 36 | Under 11 | $213K |
| Kenechukwu O Obiokoye Louisville, KY | Infectious Disease | 32 | Under 11 | $208K |
| Anmary A Fernandez de Checo Tampa, FL | Infectious Disease | 50 | Under 11 | $188K |
| Valluvan Jeevanandam Chicago, IL | Cardiac Surgery | 26 | Under 11 | $170K |
| Sandeep A Soni Poway, CA | Infectious Disease | 25 | Under 11 | $167K |
| Patricia Bartley Cleveland, OH | Infectious Disease | 52 | Under 11 | $153K |
| Shahbaz Ahmed Dallas, TX | Nephrology | 29 | Under 11 | $146K |
| Saira R Ajmal Oak Lawn, IL | Infectious Disease | 25 | Under 11 | $145K |
| Thomas D Lamarre Jr. Cincinnati, OH | Infectious Disease | 27 | Under 11 | $139K |
| Jeffrey S Reeves Louisville, KY | Internal Medicine | 21 | Under 11 | $129K |
| Deepika Buchupalli Joliet, IL | Infectious Disease | 20 | Under 11 | $112K |
| Jessica E Johnson Morgantown, WV | Internal Medicine | 17 | Under 11 | $111K |
| Joseph W Ofisi Chicago, IL | Family Practice | 20 | Under 11 | $106K |
| Jada Marie Harley Philadelphia, PA | Nurse Practitioner | 16 | Under 11 | $102K |
| Carrie L Brandstetter Saint Louis, MO | Nurse Practitioner | 17 | Under 11 | $98K |
| Neoves Diaz Miami, FL | Nurse Practitioner | 19 | Under 11 | $93K |
| Alexandria C Lucia Philadelphia, PA | Physician Assistant | 15 | Under 11 | $92K |
| Shahe E Vartivarian Houston, TX | Internal Medicine | 31 | Under 11 | $91K |
| Jose A Menajovsky West Palm Beach, FL | Infectious Disease | 17 | Under 11 | $90K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Merck Sharp & D MRK | 5,087 | $18.0M |